Print This Page

July 9, 2013

United States

Arizona—TransGenada Immunizing Shrimp Against Disease

 

TransGenada Enterprises has been awarded a Small Business Innovation Research (SBIR) grant by The National Institute of Food and Agriculture (NIFA), part of the USDA.  The grant fast-tracks TransGenada’s venture to create commercially-viable, immunized-strains of Pacific white shrimp (Litopenaeus vannamei) using their proprietary mechanism to deliver targeted and unique genetic traits.

 

Jeremy Eugene Ellis, Ph.D., the grant’s project director and TransGenada’s CEO, said, “The immune system of these shrimp will be strengthened against some of the most devastating diseases by using the latest biotechnological advances.”

 

Unlike other solutions currently available, the disease resistance imparted by TransGenada’s technology will provide shrimp with the immunity to survive disease epidemics.

 

“We appreciate the confidence the United States Department of Agriculture has placed in us, and we are looking forward to seeing the change our products will bring about,” said Ellis.

 

The cost of disease in shrimp farming has been estimated at $3 billion annually, representing up to 40% of the total production capacity of the industry.

 

TransGenada, based in Mesa, Arizona, USA, welcomes feedback and is open to collaborative efforts from industry and academic organizations.

 

Information: Andrew Ripley, Co-founder and Marketing and Business Relations Manager, TransGenada Enterprises, P.O. Box 21632, Mesa, Arizona 85177, USA (phone 1-909-542-8202, fax 1-909-912-8286, email andrew.j.ripley@gmail.com, webpage http://www.transgenada.com).

 

Source: PRWeb.  News Release.  TransGenada Enterprises.  Arizona BioTech Company Awarded Federal Grant to Fight Devastating Shrimp Diseases.  July 8, 2013.

Print This Page